X

pharmaceuticals

Moderna (MRNA) set to take advantage of opportunity in vaccines

Shares of Moderna Inc. (NASDAQ: MRNA) have gained 246% since the beginning of this year and more than 279% over…

Illumina (ILMN) is uniquely placed to offer long-term returns. Here’s why

Illumina, Inc. (NASDAQ: ILMN), a pioneer in genome sequencing technology, has strived to strengthen its unique position in the healthcare…

Humana (HUM) can offer long-term returns despite high valuation

https://www.youtube.com/watch?v=zOVB6xD8rS4 There has been a marked decrese in the number of people seeking healthcare services since the virus outbreak but…

COVID-19 vaccine development: A look at some of the pharma companies and their progress

The COVID-19 pandemic continues to go on and while the world is slowly coming out of the previously imposed strict…

Medtronic (MDT) revisits business strategy even as recovery gathers steam

https://www.youtube.com/watch?v=ukh0vaOtvBw For Medtronic plc (NYSE:MDT), the last two quarters were disappointing as healthcare institutions postponed routine medial procedures and channeled…

Will da Vinci power help Intuitive Surgical (ISRG) beat COVID blues?

Being part of a rapidly growing industry and having a successful business model can be a winning combination in difficult…

Stable demand should help PetMed (PETS) emerge stronger from pandemic

PetMed Express (NASDAQ: PETS) has been around for a long time, expanding its foothold in the lucrative pet care market…

CureVac (CVAC): Another COVID-19 stock that attracted investors

In recent times, investors have been betting on the biotech companies that are in the race to develop the COVID-19…

Veru Inc. (VERU) Q3 2020 Earnings Call Transcript

Veru Inc. (NASDAQ: VERU) Q3 2020 earnings call dated Aug. 13, 2020 Corporate Participants: Samuel Fisch -- Director, Investor Relations Mitchell Steiner -- Chairman,…

Inovio (INO) aims to produce 100 million doses of COVID-19 vaccine in 2021

Shares of INOVIO (NASDAQ: INO) were down over 23% on Tuesday, a day after the company reported second quarter 2020…

Oncology to COVID-19: Karyopharm (KPTI) CEO on what’s ahead

The oncology research space has become rather crowded these days, with numerous clinical-level companies cropping up with novel technologies. While…

Cardinal Health Inc. (CAH) Q4 2020 Earnings Call Transcript

Cardinal Health Inc. (NYSE: CAH) Q4 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Kevin Moran -- Vice President-Investor Relations Michael…

Zoetis Inc. (ZTS) Q2 2020 Earnings Call Transcript

Zoetis Inc. (NYSE: ZTS) Q2 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Steve Frank -- Vice President of Investor Relations…

Karyopharm Therapeutics Inc. (KPTI) Q2 2020 Earnings Call Transcript

Karyopharm Therapeutics Inc. (NASDAQ: KPTI) Q2 2020 earnings call dated Aug. 04, 2020 Corporate Participants: Ian Karp -- Vice President, Investor and…

Mylan N.V. (MYL) Q2 2020 Earnings Call Transcript

Mylan N.V. (NASDAQ: MYL) Q2 2020 earnings call dated Aug. 06, 2020 Corporate Participants: Melissa Trombetta -- Head of Global Investor Relations…

Highlights of Bristol-Myers Squibb Company (NYSE: BMY) Q2 2020 Earnings

https://www.youtube.com/watch?v=dYv_jstT8BY&t=18s Pharmaceutical firm Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2020 financial results on Thursday morning. The results were better…

Teva Pharmaceuticals (TEVA) Q2 2020 earnings: Reaffirms FY20 outlook

Teva Pharmaceuticals (NYSE: TEVA) beat Q2 earnings estimates, but fell short of Street's revenue targets. The drug manufacturer reported adjusted…

Amarin (AMRN) maintains revenue growth despite COVID-19 headwinds

Amarin Corporation plc (NASDAQ:AMRN) reported second quarter 2020 earnings results today. The company reported a 34% growth in total revenue…

McKesson Corp. (MCK) Q1 2021 Earnings Call Transcript

McKesson Corp. (NYSE: MCK) Q1 2021 earnings call dated Aug. 03, 2020 Corporate Participants: Holly Weiss -- Senior Vice President of Investor…

Strong performance of oncology products bode well for AbbVie (ABBV) going forward

AbbVie Inc. (NYSE: ABBV) reported better-than-expected results for the second quarter of 2020 on Friday. The company reported a 26%…

Merck & Co., Inc. (MRK) Q2 2020 Earnings Call Transcript

Merck & Co., Inc. (NYSE: MRK) Q2 2020 earnings call dated July 31, 2020 https://youtu.be/kKm2dyqbeW0 Corporate Participants: Peter Dannenbaum -- Vice President…